Skip to main content
. 2021 Mar 19;12(10):3057–3066. doi: 10.7150/jca.51413

Table 3.

Overall Survival Rates (%) of RFA versus SBRT in patients with NSCLC

Year Unmatched (95% CI) Matched (95% CI) IPTW (95% CI) Overlap Weighting (95% CI)
RFA SBRT RFA SBRT RFA SBRT RFA SBRT
1 83.3 (78.1-88.8) 83.8 (82.8-84.8) 83.2 (77.7-89.1) 81.5 (78.1-85.0) 83.4 (78.2-88.9) 83.8 (82.8-84.8) 83.6 (78.1-89.4) 82.2 (76.5-88.3)
2 63.5 (56.8-70.9) 64.3 (62.9-65.7) 62.9 (55.8-70.8) 61.5 (57.2-66.0) 63.7 (57.0-71.1) 64.3 (62.9-65.7) 63.7 (56.6-71.6) 62.1 (54.9-70.2)
3 48.5 (41.6-56.6) 48.3 (46.8-49.9) 47.3 (40.0-55.9) 41.9 (37.6-46.7) 48.5 (41.6-56.6) 48.3 (46.8-49.8) 48.4 (41.1-57.0) 46.2 (38.8-55.0)
4 38.0 (31.2-46.2) 36.5 (35.0-38.2) 36.0 (28.9-44.7) 32.5 (28.4-37.2) 37.7 (31.0-45.9) 36.5 (34.9-38.1) 37.2 (30.1-46.0) 34.3 (27.3-43.1)
5 29.1 (22.8-37.1) 27.4 (25.8-29.1) 27.3 (20.7-35.8) 23.8 (20.0-28.4) 29.0 (22.7-37.0) 27.3 (25.7-29.0) 28.4 (21.8-37.0) 25.4 (18.9-34.0)

Abbreviations: RFA: radiofrequency ablation; SBRT: stereotactic body radiotherapy; IPTW: inverse probability of treatment weight.